Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × Bevacizumab × Clear all

Phase

Status

Completed 10 Recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 47 Carcinoma, Non-Small-Cell Lung 20 Breast Neoplasms 14 Ovarian Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 9 Glioblastoma 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Uterine Cervical Neoplasms 6 Carcinoma, Renal Cell 6 Fallopian Tube Neoplasms 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 3 Recurrence 3 Pleural Effusion, Malignant 3 Nasopharyngeal Carcinoma 3 Melanoma 3 Lung Neoplasms 3 Colorectal Cancer Metastatic 3 Non-squamous Non-small Cell Lung Cancer 2 Non-small Cell Lung Cancer Metastatic 2 Neoplasms 2 Liver Neoplasms 2 Liver Metastasis Colon Cancer 2 Kidney Neoplasms 2 Intestinal Neoplasms 2 Inflammatory Breast Neoplasms 2 Glioma 2

Interventions

Cisplatin 24 Radiotherapy 16 Paclitaxel 9 Surveys and Questionnaires 8 Fluorouracil 7 pembrolizumab 6 Docetaxel 6 Cetuximab 6 durvalumab 5 apatinib 5 Low-Level Light Therapy 5 Carboplatin 5 Standard of Care 4 Radiotherapy, Intensity-Modulated 4 Celecoxib 4 atezolizumab 3 Radiation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Immunoenzyme Techniques 3 Gemcitabine 3 Drug Therapy 3 Cyclophosphamide 3 Blood Specimen Collection 3 Biopsy 3 toripalimab 2 fludarabine 2 avelumab 2 Tegafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03818061 2023-09-28

ATHENA

Centre Leon Berard

Phase 2 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡